Key Findings:  Resulting data revealed that chronic exposure to 5-HT increased visceromotor response to colorectal distention and worsened colitis (which was associated with decrease of AEA via 5-HT3 and 5-HT4 receptors). As such, the authors posit that reducing 5-HT signaling or supplementation with endocannabinoids in the gut may induce therapeutic effects in severe cases of abdominal pain with IBD.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Canada, Italy, Poland
Year of Pub:  2019
Cannabinoids Studied:  Anandamide (AEA), Endocannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Ligands Studied:  Serotonin